glp-1 gip and glucagon LY3437943, a novel triple glucagon, GIP, receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept Glucagon-like peptide-1 - Wikipedia

A 2017 systematic review published in Growth Hormone & IGF Research examined GHRH analogs broadly and concluded that while they produce measurable GH elevation, "long-term efficacy and safety data remain insufficient to support clinical recommendations outside research protocols" [6]

Most GLP-1 injections, including tirzepatide and semaglutide are taken once weekly , making them convenient compared to daily medications

One study was able to identify a relationship between a GLP-1RA and M1 macrophage polarization, alleging an antitumor effect from Semaglutide exposure (41)

Plovier H, Everard A, Druart C, Depommier C, Van Hul M, Geurts L, et al